Get the latest on Merck's Q3 2025 earnings, new drug launches, and Verona Pharma acquisition. Discover key growth drivers and financial outlook.

With vaccine sales on the decline, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. | With ...

Merck's two most important growth drivers are encountering headwinds now. While they are manageable, the company's mid-term prospects aren't strong. Merck's biggest growth drivers are cancer drug ...

The recombinant herpes zoster vaccine is effective in older adults regardless of a patient’s immunocompromised status, based on data from more than 3 million adults aged 65 years or older. The ...

Dan Baumgardt does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Donald Trump says Republican must be thrown out of Congress ‘ASAP’ ‘No drinking, no drugs, no smoking’: Eric Trump opens up about growing up in the Trump household One win from first World Series, ...

Merck headquarters in Rahway, NJ. RAHWAY, N.J.- Merck has completed its $10 billion buyout of the British biopharmaceutical company Verona. The deal was first announced in July. It brings the chronic ...

Shingle roofs are generally less expensive and easier to install than metal roofs, but metal roofs are more durable and last much longer. Some or all of the mortgage lenders featured on our site are ...

Merck & Co. is choosing to license one of Evaxion’s AI platform-based vaccine candidates, offering the Danish biotech up to $592 million for rights to the preclinical asset. Merck’s licensing is part ...

A year after his first shingles outbreak, one marathon runner’s familiar rash turned into an unexpected diagnosis Tereza Shkurtaj is a writer-reporter at PEOPLE. She has been working for PEOPLE since ...